DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow DXCM
DexCom, Inc. (DXCM) Operating cash flow
DexCom, Inc.'s operating cash flow for fiscal 2025 was $1.4B, up 45.6% from $989.5M in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.7B. Over the past ten years it has ranged from $49.0M (fiscal 2015) to $1.4B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. DexCom, Inc. ranks 8th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.4B | 45.60% |
| FY2024 | $989.5M | 32.20% |
| FY2023 | $748.5M | 11.80% |
| FY2022 | $669.5M | 51.30% |
| FY2021 | $442.5M | (6.96%) |
| FY2020 | $475.6M | 51.22% |
| FY2019 | $314.5M | 155.28% |
| FY2018 | $123.2M | 33.91% |
| FY2017 | $92.0M | 63.70% |
| FY2016 | $56.2M | 14.69% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $269.2M | (48.78%) |
| Mar 2026 | $525.6M | 78.78% |
| Dec 2025 | $294.0M | (55.45%) |
| Sep 2025 | $659.9M | 117.79% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BSX Boston Scientific Corporation compare | $4.5B |
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| PHG Koninklijke Philips N.V. compare | $2.6B |
| GEHC GE HealthCare Technologies Inc. compare | $2.1B |
| DXCM DexCom, Inc. | $1.7B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.7B |
| EW Edwards Lifesciences Corporation compare | $1.7B |
| STE STERIS plc compare | $1.3B |
| PEN Penumbra, Inc. compare | $277.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on DXCM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement